MIT engineers develop nanoparticles for personalized cancer vaccines

Engineers at MIT have created novel nanoparticles designed to deliver customized doses of cancer antigens, aiming to elicit a robust immune response against tumors. This development represents a significant advance in the field of personalized cancer immunotherapy.